GENEREX BIOTECHNOLOGY CORP
10-Q, EX-27, 2000-06-13
PHARMACEUTICAL PREPARATIONS
Previous: GENEREX BIOTECHNOLOGY CORP, 10-Q, EX-4.7, 2000-06-13
Next: GLOBAL ELECTION SYSTEMS INC, 8-K, 2000-06-13



<TABLE> <S> <C>


<ARTICLE>                     5

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          JUL-31-2000
<PERIOD-END>                               APR-30-2000
<CASH>                                       3,143,004
<SECURITIES>                                   251,801
<RECEIVABLES>                                   29,230
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                             3,509,167
<PP&E>                                       2,116,088
<DEPRECIATION>                                 191,036
<TOTAL-ASSETS>                               6,411,051
<CURRENT-LIABILITIES>                        1,762,752
<BONDS>                                              0
                                0
                                          1
<COMMON>                                        15,255
<OTHER-SE>                                   4,293,509
<TOTAL-LIABILITY-AND-EQUITY>                 6,411,051
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                             6,419,439
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              46,039
<INCOME-PRETAX>                             (6,288,775)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                         (6,288,775)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (6,288,775)
<EPS-BASIC>                                      (.42)
<EPS-DILUTED>                                    (.42)





</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission